Kabra Drugs standalone net profit rises 4.35% in the September 2026 quarter

Sales rise 61.69% to Rs 31.95 crore

Net profit of Kabra Drugs rose 4.35% to Rs 1.92 crore in the quarter ended September 2026 as against Rs 1.84 crore during the previous quarter ended September 2025. Sales rose 61.69% to Rs 31.95 crore in the quarter ended September 2026 as against Rs 19.76 crore during the previous quarter ended September 2025.

Particulars	Quarter Ended
	Sep. 2026	Sep. 2025	% Var.
Sales	31.95	19.76	62
OPM %	8.42	10.32	-
PBDT	2.69	2.22	21
PBT	2.67	2.21	21
NP	1.92	1.84	4

Powered by Capital Market - Live News